Mats Larhed

professor vid Institutionen för läkemedelskemi, Preparativ läkemedelskemi

Uppsala Biomedicinska Centrum, BMC, Husarg. 3
Box 574
751 23 UPPSALA

Vicerektor vid Universitetsledningen och ledningsråd, Vicerektorer

Segerstedthuset, Dag Hammarskjölds väg 7
752 37 Uppsala
Box 256
751 05 UPPSALA

Kort presentation

Mats Larhed was born in Västerås, Sweden, on August 21, 1964. He graduated in 1991 with a Master of Science in Pharmacy. He was appointed full Professor in Combinatorial Chemistry 2007, before being appointed as Professor in Medicinal Chemistry 2015 at Uppsala University. He is since 2020 the Vice-Rector for Medicine and Pharmacy at Uppsala University. For full CV, see link below:

Akademiska meriter: FarmD

Nyckelord: antibiotics enzyme inhibitors microwave chemistry flow chemistry angiotensin irap palladium

Detta stycke finns inte på svenska, därför visas den engelska versionen.

Mats Larhed is Professor in Medicinal Chemistry and holds at present the position as Vice-Rector for the Disciplinary Domain of Medicine and Pharmacy at Uppsala University.

Larhed is engaged in the development of EATRIS (European infrastructure for translational medicine) Swedish node, and is the Chair for SciLifeLab at Uppsala University. He is presently the Chair for the Quality assurance evaluation of research at the University of Borås.

Larhed is interested in the development of career paths at universities and he was the Chair of the Uppsala University working group on career paths 2015-16 and was responsible for the approved Uppsala Universities Charter & Code Human Resources Strategy for Researchers (HRS4R) application 2018.

Mats Larheds teaching activities have been directed toward students in pharmacy, chemical engineering and biomedicine. He early developed web-based examinations and lectures for his chemistry courses. He has overseen 22 PhD students to a final doctorate as the main supervisor and is presently supervising two PhD students.

Dr Larheds main research interests are: I) the discovery and development of new pharmaceutical agents for treatment of pulmonary fibrosis (IPF), II) development of new chemical methodologies of importance for drug discovery, and III) design and high-speed synthesis of novel radiotracers for medical imaging.

Larhed has received a number of grants from for example the Knut and Alice Wallenberg Foundation, the Swedish Research Council and the European Commission Framework Programmes as well as a couple of prestigious awards. He has published around 220 scientific articles and a number of approved patents.

Kontakta katalogansvarig vid den aktuella organisationen (institution eller motsv.) för att rätta ev. felaktigheter.

Mats Larhed
Senast uppdaterad: 2021-03-09